Exposure to triclosan augments the allergic response to ovalbumin in a mouse model of asthma.

During the last decade, there has been a remarkable and unexplained increase in the prevalence of asthma. These studies were conducted to investigate the role of dermal exposure to triclosan, an endocrine-disrupting compound, on the hypersensitivity response to ovalbumin (OVA) in a murine model of asthma. Triclosan has had widespread use in the general population as an antibacterial and antifungal agent and is commonly found in consumer products such as soaps, deodorants, toothpastes, shaving creams, mouthwashes, and cleaning supplies. For these studies, BALB/c mice were exposed dermally to concentrations of triclosan ranging from 0.75 to 3% (0.375-1.5mg/mouse/day) for 28 consecutive days. Concordantly, mice were ip injected with OVA (0.9 µg) and aluminum hydroxide (0.5mg) on days 1 and 10 and challenged with OVA (125 µg) by pharyngeal aspiration on days 19 and 27. Compared with the animals exposed to OVA alone, increased spleen weights, OVA-specific IgE, interleukin-13 cytokine levels, and numbers of lung eosinophils were demonstrated when mice were coexposed to OVA and triclosan. Statistically significant increases in OVA-specific and nonspecific airway hyperreactivity were observed for all triclosan coexposed groups compared with the vehicle and OVA controls. In these studies, exposure to triclosan alone was not demonstrated to be allergenic; however, coexposure with a known allergen resulted in enhancement of the hypersensitivity response to that allergen, suggesting that triclosan exposure may augment the allergic responses to other environmental allergens.

[1]  R. Zoeller,et al.  Developmental triclosan exposure decreases maternal, fetal, and early neonatal thyroxine: a dynamic and kinetic evaluation of a putative mode-of-action. , 2012, Toxicology.

[2]  R. Wood,et al.  Urinary levels of triclosan and parabens are associated with aeroallergen and food sensitization. , 2012, The Journal of allergy and clinical immunology.

[3]  Murugappan Ramanathan,et al.  Role of innate immunity in the pathogenesis of allergic rhinitis , 2012, Current opinion in otolaryngology & head and neck surgery.

[4]  S. Rahman,et al.  Cytokine Pathways in Allergic Disease , 2012, Toxicologic pathology.

[5]  J. Gosse,et al.  Antibacterial agent triclosan suppresses RBL-2H3 mast cell function. , 2012, Toxicology and applied pharmacology.

[6]  M. Wilkinson,et al.  Airborne contact dermatitis to triclosan , 2011, Contact dermatitis.

[7]  S. Fenton,et al.  Endocrine disrupting properties of perfluorooctanoic acid , 2011, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  J. Dowd,et al.  The Impact of Bisphenol A and Triclosan on Immune Parameters in the U.S. Population, NHANES 2003–2006 , 2010, Environmental health perspectives.

[9]  Emily K. Gibson,et al.  Triclosan exposure modulates estrogen-dependent responses in the female wistar rat. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  F. Beland,et al.  Occurrence, Efficacy, Metabolism, and Toxicity of Triclosan , 2010, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[11]  S. Barros,et al.  Triclosan inhibition of acute and chronic inflammatory gene pathways. , 2010, Journal of clinical periodontology.

[12]  J. Bach,et al.  The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update , 2010, Clinical and experimental immunology.

[13]  A. Just,et al.  Phthalates, Pesticides, and Bisphenol-A Exposure and the Development of Nonoccupational Asthma and Allergies: How Valid Are the Links? , 2009, The open allergy journal.

[14]  L. Giudice,et al.  Endocrine-disrupting chemicals: an Endocrine Society scientific statement. , 2009, Endocrine reviews.

[15]  M. Willart,et al.  The danger within: endogenous danger signals, atopy and asthma , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  S. Treves,et al.  Ryanodine Receptor Activation by Cav1.2 Is Involved in Dendritic Cell Major Histocompatibility Complex Class II Surface Expression* , 2008, Journal of Biological Chemistry.

[17]  M. Denison,et al.  In Vitro Biologic Activities of the Antimicrobials Triclocarban, Its Analogs, and Triclosan in Bioassay Screens: Receptor-Based Bioassay Screens , 2008, Environmental health perspectives.

[18]  W. Goldsmith,et al.  Respiratory Toxicologic Pathology of Inhaled Diacetyl in Sprague-Dawley Rats , 2008, Toxicologic pathology.

[19]  A. Charles,et al.  Oestrogenic and androgenic activity of triclosan in breast cancer cells , 2008, Journal of applied toxicology : JAT.

[20]  A. Calafat,et al.  Urinary Concentrations of Triclosan in the U.S. Population: 2003–2004 , 2007, Environmental health perspectives.

[21]  L. Bracci,et al.  Ca2+ signaling through ryanodine receptor 1 enhances maturation and activation of human dendritic cells , 2007, Journal of Cell Science.

[22]  S. Anderson,et al.  Exposure to the immunosuppressant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  S. Larsen,et al.  The adjuvant effect of di-(2-ethylhexyl) phthalate is mediated through a PPARalpha-independent mechanism. , 2007, Toxicology letters.

[24]  S. Rothenburger,et al.  In vivo antibacterial efficacy of MONOCRYL plus antibacterial suture (Poliglecaprone 25 with triclosan). , 2007, Surgical infections.

[25]  J. Gunsolley A meta-analysis of six-month studies of antiplaque and antigingivitis agents. , 2006, Journal of the American Dental Association.

[26]  M. Kowalski,et al.  Endocrine disrupters – potential modulators of the immune system and allergic response , 2006, Allergy.

[27]  G. Sandborgh-Englund,et al.  Pharmacokinetics of Triclosan Following Oral Ingestion in Humans , 2006, Journal of toxicology and environmental health. Part A.

[28]  A. Glaser The Ubiquitous Triclosan A common antibacterial agent exposed , 2004 .

[29]  Mark D. Hoover,et al.  Efficacy of a Technique for Exposing the Mouse Lung to Particles Aspirated from the Pharynx , 2003, Journal of toxicology and environmental health. Part A.

[30]  Kim Bottomly,et al.  Lipopolysaccharide-enhanced, Toll-like Receptor 4–dependent T Helper Cell Type 2 Responses to Inhaled Antigen , 2002, The Journal of experimental medicine.

[31]  D. C. Young,et al.  Use of antimicrobial agents in consumer products. , 2002, Archives of dermatology.

[32]  Anton Lindström,et al.  Occurrence and environmental behavior of the bactericide triclosan and its methyl derivative in surface waters and in wastewater. , 2002, Environmental science & technology.

[33]  E. Thurman,et al.  Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002, Environmental science & technology.

[34]  Maria Pettersson,et al.  Triclosan, a commonly used bactericide found in human milk and in the aquatic environment in Sweden. , 2002, Chemosphere.

[35]  M. I C H A E,et al.  Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999-2000: A National Reconnaissance , 2002 .

[36]  B. Wondimu,et al.  Effect of triclosan on interferon-gamma production and major histocompatibility complex class II expression in human gingival fibroblasts. , 2000, Journal of clinical periodontology.

[37]  J. Martin,et al.  Inositol (1,4,5)trisphosphate metabolism and enhanced calcium mobilization in airway smooth muscle of hyperresponsive rats. , 2000, American journal of respiratory cell and molecular biology.

[38]  W. Benson,et al.  Developmental evaluation of a potential non-steroidal estrogen: triclosan. , 2000, Marine environmental research.

[39]  J. Newman,et al.  Triclosan: a review of effectiveness and safety in health care settings. , 2000, American journal of infection control.

[40]  T. Ohyama,et al.  Acute toxicity, percutaneous absorption and effects on hepatic mixed function oxidase activities of 2,4,4′-trichloro-2′-hydroxydiphenyl ether (Irgasan® DP300) and its chlorinated derivatives , 1992, Archives of environmental contamination and toxicology.

[41]  Lin Yj,et al.  Triclosan: a safety profile. , 1989, American journal of dentistry.

[42]  Y. J. Lin,et al.  Triclosan: a safety profile. , 1989, American journal of dentistry.

[43]  B. Steinkjer,et al.  Contact dermatitis from triclosan (Irgasan DP 300) , 1988, Contact dermatitis.

[44]  A M Kligman,et al.  Updating the maximization test for identifying contact allergens , 1975, Contact dermatitis.

[45]  D. Howes,et al.  Percutaneous absorption and metabolism of Irgasan DP300. , 1975, Toxicology.

[46]  H. Maibach,et al.  Antimicrobials: Experimental contact sensitization in man , 1973 .

[47]  T. Furia,et al.  Toxicology of 2, 4, 4'-trichloro-2'-hydroxy-diphenyl ether. , 1969, IMS, Industrial medicine and surgery.

[48]  Lyman Fl,et al.  Toxicology of 2, 4, 4'-trichloro-2'-hydroxy-diphenyl ether. , 1968 .

[49]  I. Sarkany CONTACT DERMATITIS FROM PARABEN , 1960, The British journal of dermatology.